Search results
Results from the WOW.Com Content Network
Dana–Farber Cancer Institute (DFCI) is a comprehensive cancer treatment and research center in Boston, Massachusetts.Dana-Farber is the founding member of the Dana-Farber/Harvard Cancer Center, Harvard's Comprehensive Cancer Center designated by the National Cancer Institute, and one of the 15 clinical affiliates and research institutes of Harvard Medical School.
David M. Livingston (29 March 1941 – 17 October 2021) [1] was the Deputy Director of the Dana-Farber/Harvard Cancer Center, Emil Frei Professor of Genetics and Medicine at Harvard Medical School, Chairman of the Executive Committee for Research at Dana–Farber Cancer Institute. [2] Dr. Livingston joined the Harvard faculty in 1973. [3]
Subsequently she trained at the University of California, San Francisco and Dana–Farber Cancer Institute. In 2007, she received a masters in public health from Harvard University . [ 1 ] [ 2 ] As of 2021, Ng is a physician at the Dana–Farber Cancer Institute and a professor at Harvard Medical School . [ 3 ]
Benjamin Levine Ebert, MD, PhD, is the president and CEO of Dana–Farber Cancer Institute, the Richard and Susan Smith Professor of Medicine at Harvard Medical School and director of the Dana-Farber/Harvard Cancer Center. Ebert succeeded Laurie Glimcher as president and CEO in October 2024. [1]
Judy Ellen Garber is the director of the Center for Cancer Genetics and Prevention at the Dana–Farber Cancer Institute and a professor of medicine at Harvard Medical School. Garber previously served as president of the American Association for Cancer Research. [1] Garber's research focuses on DNA damage in breast cancer. [1]
PageNet, also known as Paging Network, Inc., was founded in 1981 by entrepreneur George Perrin and ceased in 1999.. The company grew to become the largest wireless messaging company in the world, with more than 10 million pagers in service, and $1 billion in revenues, before the paging industry's rapid decline in the late 1990s.
Thomas S. Kupper is an American physician, academic, and clinician. His work with clinical and research experience spans dermatology, cutaneous oncology, and immunology.He is the Thomas B. Fitzpatrick Professor at Harvard Medical School, and chairs the Departments of Dermatology at Brigham and Women's Hospital.
This page was last edited on 30 January 2010, at 05:33 (UTC).; Text is available under the Creative Commons Attribution-ShareAlike 4.0 License; additional terms may apply.